Abstract
Essential tremor (ET) is one of the most common forms of abnormal tremor, considered to be highly genetic with recent evidence of environmental toxicant contributions. ET is a chronic and progressive disease and is one of the most prevalent neurological diseases. The pooled prevalence of ET is estimated at 0.4–0.9% (all ages) and between 4.6 and 6.3% among persons aged 65 and older. Recent studies suggest ET results from neurodegenerative changes to neurons within the cerebellar cortex. Even mild forms of ET can result in significant difficulty feeding, dressing, walking, writing, and speaking. Diagnosis is heavily reliant on information obtained during the case history and physical examination with careful distinction between enhanced physiological tremor, drug-induced tremor, Parkinson’s disease, and dystonic tremor. ET may be treated by a variety of healthcare professionals including general practitioners, internists, geriatricians, neurologists, neurosurgeons, speech-language pathologists, and otolaryngologists. Although feeding problems are well documented in those with ET, dysphagia has not been well studied. Approximately one-third of individuals with ET develop a voice tremor with the majority being female. ET can affect voice and speech production due to tremor affecting midline cranial structures. Systematic evaluation of those with ET affecting voice and speech patterns should include auditory-perceptual ratings, acoustic measurement, nasoendoscopic imaging, and laryngeal electromyography. ET is treated using systemic medications, or local injection of botulinum toxin (BTX) into affected musculature. Voice tremor due to ET is most commonly treated using BTX injections, although recent studies show possible benefit from systemic medication.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Louis ED, Ferreira JJ. How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor. Mov Disord. 2010;25(5):534–41.
Louis ED, Broussolle E, Goetz CG, Krack P, Kaufmann P, Mazzoni P. Historical underpinnings of the term essential tremor in the late 19th century. Neurology. 2008;71(11):856–9.
Louis ED, LSt D, Pullman S. Essential tremor in childhood: a series of nineteen cases. Mov Disord. 2001;16(5):921–3.
Louis ED. The primary type of tremor in essential tremor is kinetic rather than postural: cross-sectional observation of tremor phenomenology in 369 cases. Eur J Neurol. 2013;20(4):725–7.
Louis ED, Frucht SJ, Rios E. Intention tremor in essential tremor: prevalence and association with disease duration. 2009;24(4):626–7. https://doi.org/10.1002/mds.22370.
Louis ED, Agnew A, Gillman A, Gerbin M, Viner AS. Estimating annual rate of decline: prospective, longitudinal data on arm tremor severity in two groups of essential tremor cases. J Neurol Neurosurg Psychiatry. 2011;82(7):761–5.
Robakis D, Louis ED. Head tremor in essential tremor: “yes-yes”, “no-no”, or “round and round”? Parkinsonism Relat Disord. 2016;22:98–101.
Chen W, Hopfner F, Szymczak S, Granert O, Muller SH, Kuhlenbaumer G, et al. Topography of essential tremor. Parkinsonism Relat Disord. 2017;40:58–63.
Hardesty DE, Maraganore DM, Matsumoto JY, Louis ED. Increased risk of head tremor in women with essential tremor: longitudinal data from the Rochester Epidemiology Project. Mov Disord. 2004;19(5):529–33.
Louis ED, Michalec M. Validity of a screening question for head tremor: an analysis of four essential tremor case samples. Neuroepidemiology. 2014;43(1):65–70.
Louis ED, Rios E, Applegate LM, Hernandez NC, Andrews HF. Jaw tremor: prevalence and clinical correlates in three essential tremor case samples. Mov Disord. 2006;21(11):1872–8.
Louis ED, Gerbin M. Voice handicap in essential tremor: a comparison with normal controls and Parkinson’s disease. Tremor Other Hyperkinet Mov (N Y). 2013;3.
Louis ED, Rios E, Rao AK. Tandem gait performance in essential tremor: clinical correlates and association with midline tremors. Mov Disord. 2010;25(11):1633–8.
Louis ED, Barnes L, Albert SM, Cote L, Schneier FR, Pullman SL, et al. Correlates of functional disability in essential tremor. Mov Disord. 2001;16(5):914–20.
Critchley M. Observations of essential (heredofamilial) tremor. Brain. 1949;72:113–39.
Stolze H, Petersen G, Raethjen J, Wenzelburger R, Deuschl G. The gait disorder of advanced essential tremor. Brain. 2001;124(Pt 11):2278–86.
Helmchen C, Hagenow A, Miesner J, Sprenger A, Rambold H, Wenzelburger R, et al. Eye movement abnormalities in essential tremor may indicate cerebellar dysfunction. Brain. 2003;126(Pt 6):1319–32.
Louis ED. Non-motor symptoms in essential tremor: a review of the current data and state of the field. Parkinsonism Relat Disord. 2016;22(Suppl 1):S115–8.
Schrag A, Munchau A, Bhatia KP, Quinn NP, Marsden CD. Essential tremor: an overdiagnosed condition? J Neurol. 2000;247(12):955–9.
Benito-Leon J, Bermejo-Pareja F, Louis ED. Incidence of essential tremor in three elderly populations of central Spain. Neurology. 2005;64(10):1721–5.
Louis ED, Ford B, Frucht S, Barnes LF, M XT, Ottman R. Risk of tremor and impairment from tremor in relatives of patients with essential tremor: a community-based family study. Ann Neurol. 2001;49(6):761–9.
Testa CM. Key issues in essential tremor genetics research: where are we now and how can we move forward? Tremor Other Hyperkinet Mov (N Y). 2013;3.
Tio M, Tan EK. Genetics of essential tremor. Parkinsonism Relat Disord. 2016;22(Suppl 1):S176–8.
Louis ED. Environmental epidemiology of essential tremor. Neuroepidemiology. 2008;31(3):139–49.
Louis ED, Lenka A. The Olivary hypothesis of essential tremor: time to lay this model to rest? Tremor Other Hyperkinet Mov (N Y). 2017;7:473.
Louis ED. Re-thinking the biology of essential tremor: from models to morphology. Parkinsonism Relat Disord. 2014;20(Suppl 1):S88–93.
Cerasa A, Quattrone A. Linking essential tremor to the cerebellum-neuroimaging evidence. Cerebellum. 2016;15(3):263–75.
Blonsky ER, Logemann JA, Boshes B, Fisher HB. Comparison of speech and swallowing function in patients with tremor disorders and in normal geriatric patients: a cinefluorographic study. J Gerontol. 1975;30(3):299–303.
Dromey C, Warrick P, Irish J. The influence of pitch and loudness changes on the acoustics of vocal tremor. J Speech Lang Hear Res. 2002;45(5):879–90.
Merati AL, Heman-Ackah YD, Abaza M, Altman KW, Sulica L, Belamowicz S. Common movement disorders affecting the larynx: a report from the neurolaryngology committee of the AAO-HNS. Otolaryngol Head Neck Surg. 2005;133(5):654–65.
Barkmeier-Kraemer J, Lato A, Wiley K. Development of a speech treatment program for a client with essential vocal tremor. Semin Speech Lang. 2011;32(1):43–57.
Dromey C, Smith ME. Vocal tremor and vibrato in the same person: acoustic and electromyographic differences. J Voice. 2008;22(5):541–5.
Massey EW, Paulson GW. Essential vocal tremor: clinical characteristics and response to therapy. South Med J. 1985;78(3):316–7.
Patel A, Frucht SJ. Isolated vocal tremor as a focal phenotype of essential tremor: a retrospective case review. J Clin Mov Disord. 2015;2:4.
Brown JR, Simonson J. Organic voice tremor. A tremor of phonation. Neurology. 1963;13:520–5.
Hachinski VC, Thomsen IV, Buch NH. The nature of primary vocal tremor. Can J Neurol Sci. 1975;2(3):195–7.
Ho AL, Choudhri O, Sung CK, DiRenzo EE, Halpern CH. Deep brain stimulation for essential vocal tremor: a technical report. Cureus. 2015;7(3):e256.
Sulica L, Louis ED. Clinical characteristics of essential voice tremor: a study of 34 cases. Laryngoscope. 2010;120(3):516–28.
Barkmeier JM, Case JL, Ludlow CL. Identification of symptoms for spasmodic dysphonia and vocal tremor: a comparison of expert and nonexpert judges. J Commun Disord. 2001;34(1–2):21–37.
Lederle A, Barkmeier-Kraemer J, Finnegan E. Perception of vocal tremor during sustained phonation compared with sentence context. J Voice. 2012;26(5):668 e1–9.
Twohig A, Finnegan E. The effect of vowel duration on tremor severity for patients with vocal tremor. [Undergraduate Honor’s Thesis]. Iowa City: University of Iowa; 2008.
Lundy DS, Roy S, Xue JW, Casiano RR, Jassir D. Spastic/spasmodic vs. tremulous vocal quality: motor speech profile analysis. J Voice. 2004;18(1):146–52.
Lester RA, Barkmeier-Kraemer J, Story BH. Physiologic and acoustic patterns of essential vocal tremor. J Voice. 2013;27(4):422–32.
Bove M, Daamen N, Rosen C, Wang CC, Sulica L, Gartner-Schmidt J. Development and validation of the vocal tremor scoring system. Laryngoscope. 2006;116(9):1662–7.
Hemmerich AL, Finnegan EM, Hoffman HT. The distribution and severity of tremor in speech structures of persons with vocal tremor. J Voice. 2016.
Barkmeier-Kraemer J. Updates on vocal tremor and its management. SIG 3 Perspectives on Voice and Voice Disorders. 2012;22(3):97–103.
Barkmeier-Kraemer J, editor. Evaluation and treatment of vocal tremor. Neurolaryngologie (StEMINARIES 2015–2016). Belsele: Vlaamse Vereniging voor Logopedisten; 2016.
Paige C, Hopewell BL, Gamsarian V, Myers B, Patel P, Garrett CG, et al. Characterizing the normative voice tremor frequency in essential vocal tremor. JAMA Otolaryngol Head Neck Surg. 2018; https://doi.org/10.1001/jamaoto.2018.2566. [Epub ahead of print].
Ji A, Story B, Durbin-Johnso B, Barkmeier-Kraemer J. Association of formant modulation with oropharyngeal vocal tract tremor (abstract SLP34). Voice Foundation’s 43rd Annual Symposium: Care of the Professional Voice, Philadelphia, PA. 28 May-1 Jun 2014. https://voicefoundation.org/wp-content/uploads/2014/03/Abstracts-20141.pdf. Accessed 24 Mar 2019.
Richards AL. Vocal tremor: where are we at? Curr Opin Otolaryngol Head Neck Surg. 2017;25(6):475–9.
Schneider SA, Deuschl G. The treatment of tremor. Neurotherapeutics. 2014;11(1):128–38.
Muenter MD, Daube JR, Caviness JN, Miller PM. Treatment of essential tremor with methazolamide. Mayo Clin Proc. 1991;66(10):991–7.
Busenbark K, Ramig L, Dromey C, Koller WC. Methazolamide for essential voice tremor. Neurology. 1996;47(5):1331–2.
Justicz N, Hapner ER, Josephs JS, Boone BC, Jinnah HA, Johns MM 3rd. Comparative effectiveness of propranolol and botulinum for the treatment of essential voice tremor. Laryngoscope. 2016;126(1):113–7.
Guglielmino G, Moraes BT, Villanova LC, Padovani M, Biase NG. Comparison of botulinum toxin and propranolol for essential and dystonic vocal tremors. Clinics (Sao Paulo). 2018;73:e87.
Nida A, Alston J, Schweinfurth J. Primidone therapy for essential vocal tremor. JAMA Otolaryngol Head Neck Surg. 2016;142(2):117–21.
Warrick P, Dromey C, Irish J, Durkin L. The treatment of essential voice tremor with botulinum toxin A: a longitudinal case report. J Voice. 2000;14(3):410–21.
Warrick P, Dromey C, Irish JC, Durkin L, Pakiam A, Lang A. Botulinum toxin for essential tremor of the voice with multiple anatomical sites of tremor: a crossover design study of unilateral versus bilateral injection. Laryngoscope. 2000;110(8):1366–74.
Adler CH, Bansberg SF, Hentz JG, Ramig LO, Buder EH, Witt K, et al. Botulinum toxin type A for treating voice tremor. Arch Neurol. 2004;61(9):1416–20.
Gurey LE, Sinclair CF, Blitzer A. A new paradigm for the management of essential vocal tremor with botulinum toxin. Laryngoscope. 2013;123(10):2497–501.
Kendall KA, Leonard RJ. Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor. J Voice. 2011;25(1):114–9.
Orbelo DM, Duffy JR, Hughes Borst BJ, Ekbom D, Maragos NE. Differences in botulinum toxin dosing between patients with adductor spasmodic dysphonia and essential voice tremor. J Voice. 2014;28(1):123–7.
Patel PN, Kabagambe EK, Starkweather JC, Keller M, Gamsarian V, Lee J, et al. Outcomes of onabotulinum toxin a treatment for adductor spasmodic dysphonia and laryngeal tremor. JAMA Otolaryngol Head Neck Surg. 2018;144(4):293–9.
Ho AL, Erickson-Direnzo E, Pendharkar AV, Sung CK, Halpern CH. Deep brain stimulation for vocal tremor: a comprehensive, multidisciplinary methodology. Neurosurg Focus. 2015;38(6):E6.
Ravikumar VK, Ho AL, Parker JJ, Erickson-DiRenzo E, Halpern CH. Vocal tremor: novel therapeutic target for deep brain stimulation. Brain Sci. 2016;6(4).
Hagglund P, Sandstrom L, Blomstedt P, Karlsson F. Voice tremor in patients with essential tremor: effects of deep brain stimulation of caudal zona incerta. J Voice. 2016;30(2):228–33.
Simonyan K, Frucht SJ. Long-term effect of sodium oxybate (XYREM®) in spasmodic dysphonia with vocal tremor. Tremor Other Hyperkinet Mov (NY). 2013;3.
Rumbach AF, Blitzer A, Frucht SJ, Simonyan K. An open-label study of sodium oxybate in Spasmodic dysphonia. Laryngoscope. 2017;127(6):1402–7.
Blitzer A, Brin MF, Simonyan K, Ozelius LJ, Frucht SJ. Phenomenology, genetics, and CNS network abnormalities in laryngeal dystonia: a 30-year experience. Laryngoscope. 2018;128(Suppl 1):S1–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Barkmeier-Kraemer, J.M., Louis, E.D., Smith, M.E. (2020). Essential Tremor. In: Weissbrod, P., Francis, D. (eds) Neurologic and Neurodegenerative Diseases of the Larynx. Springer, Cham. https://doi.org/10.1007/978-3-030-28852-5_17
Download citation
DOI: https://doi.org/10.1007/978-3-030-28852-5_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-28851-8
Online ISBN: 978-3-030-28852-5
eBook Packages: MedicineMedicine (R0)